Teva Pharmaceutical Industries Ltd (TEVA) — Free Cash Flow Generation Index
Teva Pharmaceutical Industries Ltd (TEVA) has a Free Cash Flow Generation Index of 0.46x as of March 2026. Free cash flow of ILA145.61 Million represents 0% of operating cash flow (ILA313.17 Million). Read TEVA total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Teva Pharmaceutical Industries Ltd Free Cash Flow Generation Index (1991–2025)
Historical FCF Generation Index trend for Teva Pharmaceutical Industries Ltd across 34 annual periods. Explore capital reinvestment ratio of Teva Pharmaceutical Industries Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Teva Pharmaceutical Industries Ltd (1991–2025)
Year-by-year Free Cash Flow Generation Index for Teva Pharmaceutical Industries Ltd. For the full company profile including market capitalisation, see market value of Teva Pharmaceutical Industries Ltd.
| Year | FCG Index | Free Cash Flow (ILA) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | ILA2.56 Billion | ILA3.10 Billion | ILA542.32 Million | ▲ +37.4% |
| 2024 | 0.60x | ILA749.00 Million | ILA1.25 Billion | ILA498.00 Million | ▼ -2.4% |
| 2023 | 0.62x | ILA842.00 Million | ILA1.37 Billion | ILA526.00 Million | ▼ -6.1% |
| 2022 | 0.66x | ILA1.04 Billion | ILA1.59 Billion | ILA548.00 Million | ▲ +121.6% |
| 2021 | 0.30x | ILA236.00 Million | ILA798.00 Million | ILA562.00 Million | ▼ -43.6% |
| 2020 | 0.52x | ILA638.00 Million | ILA1.22 Billion | ILA578.00 Million | ▼ -32.6% |
| 2019 | 0.78x | ILA419.00 Million | ILA538.00 Million | ILA119.00 Million | ▲ +6.1% |
| 2018 | 0.73x | ILA1.79 Billion | ILA2.45 Billion | ILA651.00 Million | ▼ -2.3% |
| 2017 | 0.75x | ILA2.63 Billion | ILA3.51 Billion | ILA874.00 Million | ▼ -9.3% |
| 2016 | 0.83x | ILA4.32 Billion | ILA5.22 Billion | ILA901.00 Million | ▼ -3.9% |
| 2015 | 0.86x | ILA4.77 Billion | ILA5.54 Billion | ILA772.00 Million | ▲ +5.1% |
| 2014 | 0.82x | ILA4.20 Billion | ILA5.13 Billion | ILA929.00 Million | ▲ +20.1% |
| 2013 | 0.68x | ILA2.21 Billion | ILA3.24 Billion | ILA1.03 Billion | ▼ -10.2% |
| 2012 | 0.76x | ILA3.47 Billion | ILA4.57 Billion | ILA1.10 Billion | ▲ +1.8% |
| 2011 | 0.75x | ILA3.08 Billion | ILA4.13 Billion | ILA1.05 Billion | ▼ -10.0% |
| 2010 | 0.83x | ILA3.43 Billion | ILA4.14 Billion | ILA710.00 Million | ▲ +5.3% |
| 2009 | 0.79x | ILA2.65 Billion | ILA3.37 Billion | ILA719.00 Million | ▼ -0.3% |
| 2008 | 0.79x | ILA2.55 Billion | ILA3.23 Billion | ILA681.00 Million | ▲ +12.6% |
| 2007 | 0.70x | ILA1.27 Billion | ILA1.81 Billion | ILA542.00 Million | ▼ -13.5% |
| 2006 | 0.81x | ILA1.67 Billion | ILA2.06 Billion | ILA390.00 Million | ▲ +4.8% |
| 2005 | 0.77x | ILA1.06 Billion | ILA1.37 Billion | ILA310.10 Million | ▲ +3.0% |
| 2004 | 0.75x | ILA937.80 Million | ILA1.25 Billion | ILA311.00 Million | ▲ +12.3% |
| 2003 | 0.67x | ILA419.10 Million | ILA626.60 Million | ILA207.50 Million | ▲ +22.4% |
| 2002 | 0.55x | ILA193.30 Million | ILA353.70 Million | ILA160.40 Million | ▲ +7.3% |
| 2001 | 0.51x | ILA139.08 Million | ILA273.15 Million | ILA134.07 Million | ▲ +10.7% |
| 2000 | 0.46x | ILA76.21 Million | ILA165.63 Million | ILA89.42 Million | ▼ -18.3% |
| 1999 | 0.56x | ILA86.53 Million | ILA153.61 Million | ILA67.07 Million | ▲ +160.5% |
| 1998 | -0.93x | ILA-65.40 Million | ILA70.20 Million | ILA135.60 Million | ▼ -238.5% |
| 1997 | 0.67x | ILA130.20 Million | ILA193.60 Million | ILA63.40 Million | ▲ +1084.5% |
| 1995 | -0.07x | ILA-7.20 Million | ILA105.40 Million | ILA112.60 Million | ▲ +93.7% |
| 1994 | -1.08x | ILA-41.30 Million | ILA38.20 Million | ILA79.50 Million | ▼ -436.3% |
| 1993 | -0.20x | ILA-7.60 Million | ILA37.70 Million | ILA45.30 Million | ▼ -731.7% |
| 1992 | 0.03x | ILA900.00K | ILA28.20 Million | ILA27.30 Million | ▲ +102.2% |
| 1991 | -1.45x | ILA-13.20 Million | ILA9.10 Million | ILA22.30 Million | — |